2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO32] Mini-Oral Session 32　Clinical Trial Facilitation Program 2
【E】

Sat. Feb 19, 2022 9:10 AM - 10:00 AM Room 3 (Annex 2, 1F, Kyoto International Conference Center)

Chair：Wataru Okamoto（Cancer Treatment Center, Hiroshima University Hospital），Masami Kawahara（School of Pharmacy, Aichi Gakuin University）

[MO32-4] Cost-effectiveness of SLOG vs mFOLFIRINOX as the First-line Treatment in Metastatic Pancreatic Ductal Adenocarcinoma

○Yi-Hsin Yang1, Chen-Hao Wu1, Nai-Jung Chiang1, Yan-Shen Shan2, Li-Yuan Bai4, Chung-Pin Li5, Jen-Shi Chen6, Li-Tzong Chen1,3 (1.National Institute of Cancer Research, National Health Research Institutes, Taiwan, 2.National Cheng Kung University, Taiwan, 3.Kaohsiung Medical University Hospital, Taiwan, 4.China Medical University Hospital, Taiwan, 5.Taipei Veterans General Hospital, Taiwan, 6.Linkou Chang Gung Memorial Hospital, Taiwan)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password